Why small vaccine doses are now the norm in aquaculture
In the last 20 years, fish vaccine doses have got smaller, and at some pace. From 0.2ml once being the industry standard to 0.05ml the most seen now, and some 0.025ml products available, there has been a clear direction of travel. Nils Steine, business unit director for PHARMAQ, explains why.
Fish Farm Forum is pleased to host this editorial page on behalf of Pharmaq.
PHARMAQ
SPONSOR
Vaccines and smart sea lice control helping Chilean salmon giant improve sustainability
Salmon rickettsial septicemia and Caligus sea lice are two of the major concerns affecting salmon production in Chile. Thanks to new approaches in fish-health management, Blumar Seafoods is successfully limiting their impact.
Measurement and environment are key to fish welfare
In the last decade, fish welfare has become a prominent driver of aquaculture operations. Angela Ashby, head of clinical services at PHARMAQ Analytiq, believes that the engagement of production staff in this area remains underappreciated.
Novel parasiticide part of quest for long-lasting sea lice control in Chile
Currently, almost all Atlantic salmon producers affected by caligidosis have incorporated Alpha Flux as a useful and effective tool in their parasite-control strategy.
Tracking salmon through production offers new insight into gill disease
Gills coinfected with three or more pathogens is the “norm” in Western Norway’s salmon aquaculture, new field data suggests — but Neoparamoeba perurans is that which appears to be predominantly linked with gill disease.
New system to assess gill disease could help salmon producers
Gill disease in Atlantic salmon is caused by a number of pathogens and has different clinical and pathological signs. This means that to date, there has been no standardized methodology developed for field diagnosis, despite the fact that gill health issues are a growing concern for salmon producers in all the major salmon-producing nations.
Non-medicinal delousing approaches cause damage to salmon gill tissue
New research shows that thermal and mechanical delousing techniques used in Atlantic salmon aquaculture can cause damage to gill tissue, though the health impacts of this on farmed fish remain unknown.
Managing high-tech vaccination on Canada’s salmon farms
Demand for vaccination is ever-growing in the Canadian salmon industry, and the country’s producers have made a big shift toward mechanized approaches in getting the job done.
New research on deltamethrin resistance could pave way for optimized sea lice treatment
New research on deltamethrin resistance in sea lice could help improve the effectiveness and reduce the costs of treating the global salmon industry’s “billion-dollar problem.”